Siddha Treatment for COVID 19- a Pilot Study
Phase 2
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2020/07/026632
- Lead Sponsor
- Government siddha medical college
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients with the diagnosis of laboratory confirmed COVID 19
Exclusion Criteria
1. Patients With other Acute Respiratory Distress Syndrome or other comorbidities of lungs
2. Pregnant and Lactating Mothers
3. Patients with severe primary respiratory disease or other pathogenic microbial pneumonia that needs to be identified with COVID 19.
4. patients participating in other clinical trials
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To determine the effectiveness of Siddha Medicine in Acceleration of recovery or Reduction in number of days to become test negative / symptom free in COVID 19 patientsTimepoint: 3 month
- Secondary Outcome Measures
Name Time Method To determine the reduction in risk of disease prognosis and Intensive care support <br/ ><br> <br/ ><br>Timepoint: 3 month